Capricor Therapeutics (CAPR) Q4 2024 Earnings

Nov 13Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.38
-0.26
-0.14
-0.02

Details

Expected EPS
-0.358333
Actual EPS
-0.38
Surprise EPS
-0.02
Surprise Percent
-6.05%

Description

⁨Capricor Therapeutics⁩ (⁦CAPR⁩) has reported earnings of ⁦-0.38⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts